Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.
about
A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on bloodCardiovascular disease in type 2 diabetes: challenge for treatment and preventionStroke prevention in diabetes and obesityCost effectiveness of ramipril treatment for cardiovascular risk reductionInhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetesDiabetes increases mortality after myocardial infarction by oxidizing CaMKIIDiabetes mellitus and coronary heart disease--from prevention to intervention: Part II.What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE.Ongoing trials involving angiotensin-converting enzyme inhibitors.The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.The differences between ACE inhibitor-treated and calcium channel blocker-treated hypertensive patients.Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.Recognising and treating the diabetic patient in cardiovascular care.p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction.DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.Bayesian meta-analysis of tissue angiotensin-converting enzyme inhibitors for reduction of adverse cardiovascular events in patients with diabetes mellitus and preserved left ventricular function.Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus.Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.Perindopril: beyond lowering blood pressure.A cost-effective method to characterize variation in clinical practice.Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin.Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice.Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.Type 2 diabetes and coronary heart disease: focus on myocardial infarction.Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survival.Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized
P2860
Q24806038-CA109B90-AC3A-4109-A690-098EA26FE5ADQ28181344-A2B0CA0D-08C1-444E-8393-4232EE60AF6BQ28200179-29F69FB0-AA11-4974-9CA5-667BB574ADDAQ28362658-4E826A0A-A800-43F8-BC03-8B41FF74E14EQ28364325-695E932B-6178-4A7E-97B9-980E85695171Q30540314-0619241E-0832-4C08-B8E8-FB8B82478EB4Q34099605-3BD1EE1B-04E3-4AD3-A99E-20A0FDD0CE7FQ34530229-9D81E167-EF4E-46F9-8D4C-82901F05A0D1Q35001043-0BEEFB9B-D429-49EE-A260-C36DCF7DE515Q35182095-BE05203F-5AAD-46A4-AEB7-9ACCF5120370Q35561932-ED2245F8-797E-4517-8156-A3442C7FCE25Q35580134-2251AAD2-7A7C-4786-8547-5C85D68998B6Q35586294-572690BE-6A00-4360-A8A7-8BD0A57A6D09Q35837423-40BDEA76-1009-4110-BD7C-B8B035C7CE65Q36010298-3E8717A6-82F2-4780-963C-74CDC51FCFA3Q36401585-6F93D5D6-DF34-4AAC-9CEE-5859E162C69AQ36536316-FCECAD94-57AB-4C9B-BCB0-351E4E8474F5Q36835871-73A22DDB-749B-4037-BBC0-768427D08929Q37104532-EC18FE25-7859-4674-BF87-C7EAAA7C9DEFQ37505849-9A551E4A-C12E-4E68-A44B-FFF9D2082E6DQ38079914-6D2EF58A-3818-4A15-8851-E675AE87A297Q38890008-7E1DB6BD-8D6F-4886-8128-266546F2EB9AQ40097875-840F2378-296D-4F5D-9BE1-EE017771448CQ42613525-15A0BD3E-2247-4FE2-AFFA-2C8A4961BE2FQ44355160-45A46066-9326-4D1B-93E2-2AB5EB303F2DQ44460187-331F1298-4AF0-4AB7-9EA3-1E63E7653F5EQ44705248-ED25540A-0129-4E3B-AD88-429A33FAC764Q44705824-1CAFB96C-4229-4456-8D4F-556ED4ACE566Q44965057-CAA504E1-22F9-4791-B465-CF4E3113C3A0Q45025736-61FA997B-7CA9-40F4-9485-117209A44544Q46133991-CDF53EB2-FF75-4198-94A6-475F46A472F8Q46878364-98236357-0CC5-41B7-8064-CEB3701F7162Q47751342-CB04558F-1730-43BC-B3D6-9DBE47AA2430Q47761665-AB14DE50-97F1-40B8-A909-AC20C067E196Q48258234-5239AD23-F301-4A50-9E63-ECC0B35D10A1Q50653081-7EBFF9BE-BBCE-41C3-8DDD-2EAD8240E757
P2860
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@ast
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@en
type
label
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@ast
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@en
prefLabel
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@ast
Effect of the ACE inhibitor li ...... : data from the GISSI-3 study.
@en
P2093
P1433
P1476
Effect of the ACE inhibitor li ...... n: data from the GISSI-3 study
@en
P2093
P304
P356
10.1161/01.CIR.96.12.4239
P407
P577
1997-12-01T00:00:00Z